KIT and gastrointestinal stromal tumor: Sunitinib or Sorafenib is a tyrosine kinase inhibitor molecule that targets KIT and has antiangiogenic effects, which is utilized for the treatment of advanced gastrointestinal stromal tumors in patients who fail Imatinib therapy.